# NOX1

## Overview
NOX1 is a gene that encodes the protein NADPH oxidase 1, a transmembrane enzyme that plays a pivotal role in the generation of reactive oxygen species (ROS) within cells. As a member of the NADPH oxidase family, NOX1 is involved in various cellular processes, including cell signaling, growth, and defense mechanisms. The protein is characterized by its six transmembrane domains and a cytosolic dehydrogenase domain, which facilitate electron transfer from NADPH to oxygen, resulting in the production of superoxide and other ROS (Streeter2014Phosphorylation; Helmcke2009Identification). NOX1 is predominantly expressed in epithelial cells, particularly in the gastrointestinal tract, where it contributes to host defense and the maintenance of tissue integrity (Brandes2014Nox). The activity of NOX1 is regulated through interactions with various cytosolic subunits and signaling pathways, underscoring its importance in both physiological and pathological contexts, such as inflammatory bowel diseases (Schwerd2018NOX1).

## Structure
NOX1 (NADPH oxidase 1) is a transmembrane protein that serves as the catalytic core of a multi-subunit NADPH oxidase enzyme complex. It is composed of six transmembrane domains and a cytosolic dehydrogenase domain, which are involved in electron transfer from NADPH to oxygen, producing reactive oxygen species (ROS) such as superoxide (Streeter2014Phosphorylation; Helmcke2009Identification). The transmembrane domain contains conserved histidine residues that coordinate heme groups, essential for electron transfer (Baniulis2005Evaluation).

The cytosolic tail of NOX1 is crucial for its activity, and phosphorylation at threonine 429 by protein kinase C-βI is necessary for its interaction with the NoxA1 activation domain, facilitating the recruitment of cytosolic proteins to the membrane (Streeter2014Phosphorylation). This post-translational modification is vital for the assembly and activation of the NOX1 complex, which includes other proteins like p47phox and NoxA1 (Streeter2014Phosphorylation).

NOX1 shares structural similarities with other Nox family members, including conserved flavin- and NADPH-binding sites in the carboxy-terminal domain (Baniulis2005Evaluation). The protein's structure and activity are influenced by its subcellular localization, typically found in the plasma membrane (Helmcke2009Identification).

## Function
NOX1 (NADPH oxidase 1) is an enzyme that plays a crucial role in the production of reactive oxygen species (ROS) in various cellular processes. In healthy human cells, NOX1 is primarily active in the plasma membrane, caveolae, and endosomes, where it facilitates the conversion of superoxide to hydrogen peroxide, a type of ROS (Lassègue2010NADPH). This ROS production is essential for normal cellular signaling, influencing processes such as cell growth, proliferation, differentiation, apoptosis, cytoskeletal organization, and migration (Manea2010NADPH).

NOX1 is involved in redox signaling pathways that regulate cell adhesion and migration, particularly in smooth muscle cells and epithelial cells. It contributes to the activation of signaling pathways that reinforce cell adhesion, alter cell shape, and affect gene expression, which are vital for maintaining tissue integrity (Schröder2014NADPH). NOX1 also plays a role in the regulation of vascular tone and is implicated in the physiological remodeling of blood vessels in response to shear stress (Lassègue2010NADPH).

The enzyme's activity is regulated by various signaling pathways, including those involving protein kinase C, phospholipases, and PI3K, and it requires interaction with cytosolic subunits like Noxa1 and p47phox for full activation (Lassègue2010NADPH). In the gastrointestinal tract, NOX1 is highly expressed in epithelial cells, where it may contribute to host defense mechanisms (Brandes2014Nox).

## Clinical Significance
Mutations in the NOX1 gene have been implicated in various inflammatory bowel diseases (IBD), particularly very-early-onset IBD (VEOIBD). These mutations can lead to a loss of function in the NOX1 enzyme, resulting in diminished production of reactive oxygen species (ROS), which are crucial for maintaining the integrity of the intestinal epithelial barrier. This impairment can contribute to the pathogenesis of IBD by affecting epithelial differentiation and goblet cell function, essential for maintaining the mucus barrier in the colon (Schwerd2018NOX1). 

In particular, the NOX1 p.R241C variant, identified in a case of VEOIBD, was found to reduce ROS generation and antibacterial capacity in intestinal epithelial cells. This variant, along with a common variant in the CYBA gene, affects NOD2-mediated immune responses, potentially leading to disturbed intestinal mucosal barrier function and increased susceptibility to intestinal inflammation (Lipinski2019Missense). 

NOX1 mutations have also been associated with alterations in pro-inflammatory signaling pathways, such as NF-κB activation, which can exacerbate inflammatory responses in the gut (Lipinski2019Missense). These findings highlight the clinical significance of NOX1 in maintaining intestinal health and its potential role in the development of inflammatory diseases.

## Interactions
NOX1 (NADPH oxidase 1) interacts with several proteins to form a functional NADPH oxidase complex. It requires the presence of NOXO1 (NOX organizer 1) and NOXA1 (NOX activator 1) for its activation. NOXO1 and NOXA1 are homologous to the cytoplasmic subunits p47phox and p67phox, respectively, which are known to activate the phagocyte NADPH oxidase. These proteins are predominantly expressed in the colon epithelium and enable superoxide generation by NOX1 when co-expressed (Bánfi2003Two).

NOX1 also interacts with p22phox, a membrane-bound subunit essential for the formation of a functionally active NADPH oxidase. This interaction is crucial for the stabilization and expression of p22phox, enhancing its presence in cells (Ambasta2004Direct). Additionally, NOX1 interacts with Rac1, a GTPase that is involved in its activation. The phosphorylation of NOXA1 by MAP kinases and protein kinases C and A modulates its interaction with Rac1 and NOX1, preventing hyperactivation of the NOX1 complex (Kroviarski2010Phosphorylation).

The interaction between NOX1 and its regulatory partners is critical for its role in producing reactive oxygen species, which are involved in various cellular processes, including host defense and inflammation (Kroviarski2010Phosphorylation).


## References


[1. (Kroviarski2010Phosphorylation) Yolande Kroviarski, Maya Debbabi, Rafik Bachoual, Axel Pe´rianin, Marie‐Anne Gougerot‐Pocidalo, Jamel El‐Benna, and Pham My‐Chan Dang. Phosphorylation of nadph oxidase activator 1 (noxa1) on serine 282 by map kinases and on serine 172 by protein kinase c and protein kinase a prevents nox1 hyperactivation. The FASEB Journal, 24(6):2077–2092, January 2010. URL: http://dx.doi.org/10.1096/fj.09-147629, doi:10.1096/fj.09-147629. This article has 54 citations.](https://doi.org/10.1096/fj.09-147629)

[2. (Ambasta2004Direct) Rashmi K. Ambasta, Pravir Kumar, Kathy K. Griendling, Harald H.H.W. Schmidt, Rudi Busse, and Ralf P. Brandes. Direct interaction of the novel nox proteins with p22phox is required for the formation of a functionally active nadph oxidase. Journal of Biological Chemistry, 279(44):45935–45941, October 2004. URL: http://dx.doi.org/10.1074/jbc.m406486200, doi:10.1074/jbc.m406486200. This article has 419 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m406486200)

[3. (Brandes2014Nox) Ralf P. Brandes, Norbert Weissmann, and Katrin Schröder. Nox family nadph oxidases: molecular mechanisms of activation. Free Radical Biology and Medicine, 76:208–226, November 2014. URL: http://dx.doi.org/10.1016/j.freeradbiomed.2014.07.046, doi:10.1016/j.freeradbiomed.2014.07.046. This article has 523 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.freeradbiomed.2014.07.046)

[4. (Schröder2014NADPH) Katrin Schröder. Nadph oxidases in redox regulation of cell adhesion and migration. Antioxidants &amp; Redox Signaling, 20(13):2043–2058, May 2014. URL: http://dx.doi.org/10.1089/ars.2013.5633, doi:10.1089/ars.2013.5633. This article has 47 citations.](https://doi.org/10.1089/ars.2013.5633)

[5. (Streeter2014Phosphorylation) Jennifer Streeter, Brandon M. Schickling, Shuxia Jiang, Bojana Stanic, William H. Thiel, Lokesh Gakhar, Jon C.D. Houtman, and Francis J. Miller. Phosphorylation of nox1 regulates association with noxa1 activation domain. Circulation Research, 115(11):911–918, November 2014. URL: http://dx.doi.org/10.1161/CIRCRESAHA.115.304267, doi:10.1161/circresaha.115.304267. This article has 45 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/CIRCRESAHA.115.304267)

[6. (Schwerd2018NOX1) T Schwerd, RV Bryant, S Pandey, M Capitani, L Meran, J-B Cazier, J Jung, K Mondal, M Parkes, CG Mathew, K Fiedler, DJ McCarthy, PB Sullivan, A Rodrigues, SPL Travis, C Moore, J Sambrook, WH Ouwehand, DJ Roberts, J Danesh, RK Russell, DC Wilson, JR Kelsen, R Cornall, LA Denson, S Kugathasan, UG Knaus, EG Serra, CA Anderson, RH Duerr, DPB McGovern, J Cho, F Powrie, VSW Li, AM Muise, and HH Uhlig. Nox1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunology, 11(2):562–574, March 2018. URL: http://dx.doi.org/10.1038/mi.2017.74, doi:10.1038/mi.2017.74. This article has 67 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/mi.2017.74)

[7. (Baniulis2005Evaluation) Danas Baniulis, Yoko Nakano, William M. Nauseef, Botond Banfi, Guangjie Cheng, David J. Lambeth, James B. Burritt, Ross M. Taylor, and Algirdas J. Jesaitis. Evaluation of two anti-gp91phox antibodies as immunoprobes for nox family proteins: mab 54.1 recognizes recombinant full-length nox2, nox3 and the c-terminal domains of nox1-4 and cross-reacts with grp 58. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1752(2):186–196, September 2005. URL: http://dx.doi.org/10.1016/j.bbapap.2005.07.018, doi:10.1016/j.bbapap.2005.07.018. This article has 14 citations.](https://doi.org/10.1016/j.bbapap.2005.07.018)

[8. (Lassègue2010NADPH) Bernard Lassègue and Kathy K. Griendling. Nadph oxidases: functions and pathologies in the vasculature. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(4):653–661, April 2010. URL: http://dx.doi.org/10.1161/atvbaha.108.181610, doi:10.1161/atvbaha.108.181610. This article has 466 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/atvbaha.108.181610)

[9. (Bánfi2003Two) Botond Bánfi, Robert A. Clark, Klaus Steger, and Karl-Heinz Krause. Two novel proteins activate superoxide generation by the nadph oxidase nox1. Journal of Biological Chemistry, 278(6):3510–3513, February 2003. URL: http://dx.doi.org/10.1074/jbc.c200613200, doi:10.1074/jbc.c200613200. This article has 383 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.c200613200)

[10. (Lipinski2019Missense) Simone Lipinski, Britt-Sabina Petersen, Matthias Barann, Agnes Piecyk, Florian Tran, Gabriele Mayr, Marlene Jentzsch, Konrad Aden, Stephanie T. Stengel, Ulrich C. Klostermeier, Vrunda Sheth, David Ellinghaus, Tobias Rausch, Jan O. Korbel, Michael Nothnagel, Michael Krawczak, Christian Gilissen, Joris A. Veltman, Michael Forster, Peter Forster, Clarence C. Lee, Annette Fritscher-Ravens, Stefan Schreiber, Andre Franke, and Philip Rosenstiel. Missense variants in nox1 and p22phox in a case of very-early-onset inflammatory bowel disease are functionally linked to nod2. Molecular Case Studies, 5(1):a002428, February 2019. URL: http://dx.doi.org/10.1101/mcs.a002428, doi:10.1101/mcs.a002428. This article has 13 citations.](https://doi.org/10.1101/mcs.a002428)

[11. (Helmcke2009Identification) Ina Helmcke, Sabine Heumüller, Ritva Tikkanen, Katrin Schröder, and Ralf P. Brandes. Identification of structural elements in nox1 and nox4 controlling localization and activity. Antioxidants &amp; Redox Signaling, 11(6):1279–1287, June 2009. URL: http://dx.doi.org/10.1089/ars.2008.2383, doi:10.1089/ars.2008.2383. This article has 118 citations.](https://doi.org/10.1089/ars.2008.2383)

[12. (Manea2010NADPH) Adrian Manea. Nadph oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology. Cell and Tissue Research, 342(3):325–339, November 2010. URL: http://dx.doi.org/10.1007/s00441-010-1060-y, doi:10.1007/s00441-010-1060-y. This article has 128 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00441-010-1060-y)